Trial Profile
A Two-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Four MR Formulations and Food Effect of GW427353 (Solabegron) in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Solabegron (Primary)
- Indications Irritable bowel syndrome; Overactive bladder
- Focus Pharmacokinetics
- Sponsors GSK
- 20 Feb 2007 New trial record.